Publication: Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?
Date
2005-01
ISSN
Published
2005-01
Author(s)
Jack, William
Lanjouw, Jean O.
Abstract
A public economics framework is used to
consider how pharmaceuticals should be priced when at least
some of the research and development incentive comes from
sales revenues. Familiar techniques of public finance are
used to relax some of the restrictions implied in the
standard use of Ramsey pricing. Under the more general
model, poor countries should not necessarily cover even
their own marginal costs, and the pricing structure is not
related to that which will be chosen by a monopolist in a
simple way. This framework is then used to examine ongoing
debates regarding the international patent system as
embodied in the world trade organization's agreement on
trade-related aspects of intellectual property rights.
Link to Data Set
Citation
“Jack, William; Lanjouw, Jean O.. 2005. Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?. World Bank Economic Review. © Published by Oxford University Press on behalf of the World Bank. http://hdl.handle.net/10986/16481 License: CC BY-NC-ND 3.0 IGO.”
Report Series
Other publications in this report series
Journal
Journal
World Bank Economic Review
1564-698X
Journal Volume
Journal Volume
Journal Issue
Journal Issue
Collections
Associated URLs
Associated content
Citations
-
Cited 18 times in Scopus (View citations)